简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-05-16 10:38 Q3 Medical Devices Limited Enters into a Distribution Agreement with Medtronic for its Biodegradable Biliary and Pancreatic Stent
2019-05-15 13:35 Takeda to Highlight New Research into the Long-term Complications of Chronic Hypoparathyroidism at the European Congress of Endocrinology 2019 Annual Meeting
2019-05-14 15:20 SpeeDx Receives Clearance for PlexPCR Respiratory Virus Test
2019-05-14 15:17 Masimo and Mindray Announce Expanded Partnership
2019-05-13 13:42 LeapFrog Breaks Impact Investing Record, with $700M Emerging Markets Fund
2019-05-10 16:52 Major Initiative to Close Information Gaps on Cross Border Reproduction in the Asia Pacific
2019-05-10 14:47 Mary Kay Unveils Breakthrough Research on the Impact of Antioxidants and Vitamin C on Skin Health and Appearance
2019-05-10 09:56 U.S. Food & Drug Administration Accepts Takeda’s Biologics License Application for a Subcutaneous Formulation of Vedolizumab (Entyvio®) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis
2019-05-09 12:08 Takeda Expands Oncology Research, Demonstrating Commitment to Patient Community at 15th International Symposium on Myelodysplastic Syndromes
2019-05-09 09:50 Takeda Simplifies Portfolio and Accelerates Deleveraging Through Two Divestitures
2019-05-08 14:23 Focus on the bleak ramifications of falling fertility rates in South East Asian countries
2019-05-08 14:20 L-GA, a Korean Confectionery Company, Launches Its Candy-Type MultiVita C365 Series in China
2019-05-08 10:31 Fifty Countries Represented at Hong Kong Congress in a Powerful Expression of Scientific Exchange in the Field of Assisted Reproduction
2019-05-08 10:28 Decline in Access to Contraceptives with Younger and Poorer Asian Women at Risk
2019-05-08 10:19 Apax Funds, CPPIB and PSP Investments Agree to Sell Acelity and its KCI Subsidiaries to 3M for $6.725 Billion
2019-05-08 09:55 US FDA Action Enables Millions of American Smokers to Give Up Cigarettes
2019-05-08 09:53 Clover Biopharmaceuticals Receives NMPA Approval for SCB-313 (TRAIL-Trimer) to Initiate Clinical Trials in China
2019-05-08 09:48 Analysis Showed Oral Ozanimod Reduced Brain Volume Loss Across All Age Subgroups in Adults with Relapsing Multiple Sclerosis
2019-05-07 16:15 Arthur D. Little Report Explores Impact of “Ultra-targeted” Healthcare
2019-05-07 15:49 Valence Advises INEOS on Acquisition of N.A. TiO2 Business from Tronox

Business Wire Weibo

Press Releases

Latest Releases